Merck & Co. at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Merck & Co. brings 1 presentation to SITC 2026 in Phoenix, and exhibits at Booth 1228. Its presence centres on checkpoint inhibitors, bispecifics and other new agents, along with clinical trials and patient care. Merck & Co., called MSD beyond the US and Canada, brings a wide oncology research and clinical development effort.
| Organization | SITC 2026 Attendance |
|---|---|
Merck & Co. Rahway, NJ | |
Global pharmaceutical company, known as MSD outside the US and Canada, running a broad oncology research and clinical development program. | Booth Exhibiting at Booth 1228 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Session Wed Nov 4 3:10pm–3:55pm Talk Thu Nov 5 5:55pm–6:15pm Session Thu Nov 5 6:55pm–7:15pm Session Fri Nov 6 3:55pm–5:30pm Biotech Session: The Next Generation of Off-the-Shelf IO
|
Instantly find 20 buyers from Merck & Co.
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction